Literature DB >> 431563

Disopyramide.

J Koch-Weser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 431563     DOI： 10.1056/NEJM197904263001705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 2.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

3.  Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.

Authors:  H Echizen; M Nakura; T Saotome; S Minoura; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

4.  Fatal torsade de pointes following jaundice in a patient treated with disopyramide.

Authors:  A Schattner; J Gindin; D Geltner
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

5.  Severe hypoglycemia associated with disopyramide.

Authors:  J M Nappi; S Dhanani; J R Lovejoy; C VanderArk
Journal:  West J Med       Date:  1983-01

Review 6.  Protein binding displacement interactions and their clinical importance.

Authors:  J C McElnay; P F D'Arcy
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

7.  Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.

Authors:  H Echizen; S Saima; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

8.  Plasma concentrations and protein binding of disopyramide and mono-N-dealkyldisopyramide during chronic oral disopyramide therapy.

Authors:  M L Aitio
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

9.  Disopyramide induced second and third degree atrioventricular block in patients with bifascicular block. An acute stress test to predict atrioventricular block progression.

Authors:  L Bergfeldt; M Rosenqvist; H Vallin; O Edhag
Journal:  Br Heart J       Date:  1985-03

10.  Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.

Authors:  T Tanabe
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.